ClassID:

110380

C12N2740/15042 - CPC Classification

Classification description:

Reverse transcribing RNA viruses; Details; Retroviridae; Lentivirus, not HIV, e.g. FIV, SIV; Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule

Recent Application in this class:
#1
20260139247
2026-05-21

ENGINEERED ENVELOPED VECTORS AND METHODS OF USE THEREOF

#2
20260062675
2026-03-05

SIRPalpha-SILENCED NATURAL KILLER (NK) CELLS

#3
20260061029
2026-03-05

P21 Expressing Monocytes for Cancer Cell Therapy

#4
20250339384
2025-11-06

MODIFIED RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF

#5
20250136994
2025-05-01

COMPOSITIONS AND METHODS TO RESTORE PATERNAL UBE3A GENE EXPRESSION IN HUMAN ANGELMAN SYNDROME

#6
20250064976
2025-02-27

ENGINEERED PNMA PROTEINS AND DELIVERY SYSTEMS THEREOF

#7
20250002937
2025-01-02

EBOLA PSEUDOTYPED VECTORS AND METHODS OF USE THEREOF

#8
20240417444
2024-12-19

COMPOSITIONS AND METHODS FOR TREATING INTERLEUKIN 7 RECEPTOR DEFICIENCY

#9
20240368624
2024-11-07

GENOMIC RNA PACKAGING ENHANCER ELEMENT

#10
20240327862
2024-10-03

Methods of Treating Rheumatoid Arthritis Using RNA-Guided Genome Editing of HLA Gene

#11
20240294942
2024-09-05

RETARGETED RETROVIRAL VECTORS AND COMPOSITIONS OR METHODS OF USE THEREOF

#12
20240165156
2024-05-23

Methods and composition for gene delivery using an engineered viral particle

#13
20240150711
2024-05-09

PERSONALIZED REDIRECTION AND REPROGRAMMING OF T CELLS FOR PRECISE TARGETING OF TUMORS

#14
20240108756
2024-04-04

COMPOSITIONS AND METHODS FOR USING ALTERNATIVE SPLICING TO CONTROL SPECIFICITY OF GENE THERAPY

#15
20240101616
2024-03-28

DAP10/12 BASED CARS ADAPTED FOR RUSH

#16
20240067958
2024-02-29

ENGINEERED ENVELOPED VECTORS AND METHODS OF USE THEREOF

#17
20230103771
2023-04-06

CRISPR-Cas13 crRNA Arrays

#18
20230036685
2023-02-02

Novel Vectors and Uses Thereof

#19
20220354890
2022-11-10

CHIMERIC ANTIGEN RECEPTOR TARGETING CLL1 AND USE THEREOF

#20
20220347316
2022-11-03

CD25 PRE-SELECTIVE COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE

#21
20220347215
2022-11-03

SIRPalpha-SILENCED NATURAL KILLER (NK) CELLS

#22
20220340876
2022-10-27

VIRAL TARGETING OF HEMATOPOIETIC STEM CELLS

#23
20220333070
2022-10-20

INDUCTION OF FUNCTIONAL ASTROCYTES FROM PLURIPOTENT STEM CELLS

#24
20220326225
2022-10-13

PLURIPOTENT STEM CELL, NERVE CELL, AND APPLICATION THEREOF

#25
20220323497
2022-10-13

CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF

#26
20220315894
2022-10-06

Method for Transduction of T Cells in the Presence of Malignant Cells

#27
20220296643
2022-09-22

Methods and composition for gene delivery using an engineered viral particle

#28
20220282220
2022-09-08

METHOD FOR PREPARATION OF IMMORTALIZED STEM CELL LINE AND USE THEREOF

#29
20220275339
2022-09-01

HEPATIC PRECURSOR-LIKE CELL LINE, CONSTRUCTION METHODS, AND APPLICATIONS IN THE FIELD OF THE BIOARTIFICIAL LIVERS

#30
20220265711
2022-08-25

ENGINEERED IMMUNE CELLS COMPRISING A RECOGNITION MOLECULE

#31
20220257709
2022-08-18

P21 Expressing Monocytes for Cancer Cell Therapy

#32
20220233652
2022-07-28

Pharmaceutical Compositions Comprising Integration-Promoting Peptides

#33
20220154214
2022-05-19

Lentivirus packaging system comprising a synthetic positive feedback loop

#34
20210332368
2021-10-28

Compositions and methods to restore paternal UBE3A gene expression in human Angelman syndrome

#35
20210309966
2021-10-07

Methods of improving vector transduction efficiency into T lymphocytes

#36
20210283179
2021-09-16

Methods and composition for gene delivery using an engineered viral particle

#37
20210269804
2021-09-02

MULTIPLEXED SHRNAS AND USES THEREOF

#38
20210024607
2021-01-28

EXPRESSION VECTORS FOR CHIMERIC ENGULFMENT RECEPTORS, GENETICALLY MODIFIED HOST CELLS, AND USES THEREOF

#39
20200347406
2020-11-05

Process for modifying human cell lines to produce factor VII

#40
20200331975
2020-10-22

DAP10/12 BASED CARS ADAPTED FOR RUSH

#41
20200318081
2020-10-08

VECTORS WITH PROMOTER AND ENHANCER COMBINATIONS FOR TREATING PHENYLKETONURIA

#42
20200224218
2020-07-16

Methods to enhance myocardial regeneration and/or repair

#43
20200199616
2020-06-25

Methods of treating rheumatoid arthritis using RNA-guided genome editing of HLA gene

#44
20200197537
2020-06-25

CD25 PRE-SELECTIVE COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE

#45
20200087682
2020-03-19

Compositions and methods for treating phenylketonuria

#46
20190211357
2019-07-11

Genomic RNA packaging enhancer element

#47
20190136262
2019-05-09

Lentivirus packaging system comprising a synthetic positive feedback loop

#48
20190105381
2019-04-11

METHOD FOR PREPARING VIRAL PARTICLES WITH CYCLIC DINUCLEOTIDE AND USE OF SAID PARTICLES FOR TREATING CANCER

#49
20180223313
2018-08-09

Lentiviral protein delivery system for RNA-guided genome editing

#50
20170240899
2017-08-24

Multiplexed shRNAs and uses thereof

#51
20170166866
2017-06-15

Methods of improving vector transduction efficiency into T lymphocytes

#52
20160340732
2016-11-24

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING NUCLEOTIDE REPEAT DISORDERS

#53
20160333374
2016-11-17

Pseudotyped lentiviral vectors

#54
20150322459
2015-11-12

Genomic RNA packaging enhancer element

#55
20150283266
2015-10-08

CD25 PRE-SELECTIVE COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE

#56
20150111822
2015-04-23

WNT7A compositions and method of using the same

#57
20150057332
2015-02-26

Methods for the treatment of nonalcoholic steatohepatitis